Perceptive Advisors’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,647
| Closed | -$158K | – | 122 |
|
|
2022
Q3 | $158K | Hold |
10,647
| – | – | ﹤0.01% | 112 |
|
|
2022
Q2 | $620K | Hold |
10,647
| – | – | 0.02% | 104 |
|
|
2022
Q1 | $178M | Hold |
10,647
| – | – | 3.57% | 7 |
|
|
2021
Q4 | $10.4M | Buy |
10,647
+2,687
| +34% | +$3.79M | 0.16% | 91 |
|
|
2021
Q3 | $15.3M | Hold |
7,960
| – | – | 0.22% | 80 |
|
|
2021
Q2 | $21.2M | Hold |
7,960
| – | – | 0.28% | 81 |
|
|
2021
Q1 | $33.1M | Hold |
7,960
| – | – | 0.44% | 56 |
|
|
2020
Q4 | $45.7M | Hold |
7,960
| – | – | 0.49% | 48 |
|
|
2020
Q3 | $48.4M | Hold |
7,960
| – | – | 0.71% | 38 |
|
|
2020
Q2 | $44.3M | Hold |
7,960
| – | – | 0.72% | 36 |
|
|
2020
Q1 | $29.6M | Buy |
7,960
+2,000
| +34% | +$11.5M | 0.77% | 33 |
|
|
2019
Q4 | $29.8M | Buy |
5,960
+597
| +11% | +$2.08M | 0.6% | 39 |
|
|
2019
Q3 | $12.7M | Buy |
5,363
+1,150
| +27% | +$2.83M | 0.34% | 52 |
|
|
2019
Q2 | $10.4M | Hold |
4,213
| – | – | 0.24% | 63 |
|
|
2019
Q1 | $12.7M | Buy |
+4,213
| New | +$8.93M | 0.36% | 54 |
|
|
2018
Q3 | – | Sell |
-1,765
| Closed | -$1.74M | – | 141 |
|
|
2018
Q2 | $1.74M | Hold |
1,765
| – | – | 0.05% | 89 |
|
|
2018
Q1 | $9.07M | Buy |
1,765
+75
| +4% | +$496K | 0.26% | 62 |
|
|
2017
Q4 | $9.09M | Buy |
+1,690
| New | +$15.7M | 0.3% | 55 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 170 |
|
|
2017
Q1 | – | Sell |
-331
| Closed | -$1.66M | – | 221 |
|
|
2016
Q4 | $3.77M | Sell |
331
-179
| -35% | -$2.51M | 0.27% | 67 |
|
|
2016
Q3 | $7.12M | Buy |
510
+253
| +98% | +$3.61M | 0.46% | 55 |
|
|
2016
Q2 | $3.91M | Buy |
257
+169
| +192% | +$2.31M | 0.32% | 68 |
|
|
2016
Q1 | $1.09M | Buy |
+88
| New | +$1.14M | 0.1% | 98 |
|
Other funds holding AGRX
VF
IA
ASN
SM